D.E. Shaw & Co
PETX

D.E. Shaw & Co’s Aratana Therapeutics, Inc. PETX Stock Holding History

D.E. Shaw & Co’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-53,420
Closed -$327K – 3841
2017
Q3 		$327K Buy
53,420
+15,023
+39% +$95.1K ﹤0.01% 3108
2017
Q2 		$278K Buy
38,397
+26,277
+217% +$162K ﹤0.01% 3063
2017
Q1 		$64K Sell
12,120
-117,459
-91% -$793K ﹤0.01% 3218
2016
Q4 		$930K Sell
129,579
-145,403
-53% -$1.18M ﹤0.01% 2503
2016
Q3 		$2.57M Buy
+274,982
New +$2.28M ﹤0.01% 1728
2016
Q2 		– Sell
-158,253
Closed -$874K – 3629
2016
Q1 		$874K Buy
158,253
+146,206
+1,214% +$550K ﹤0.01% 2441
2015
Q4 		$67K Buy
+12,047
New +$79.6K ﹤0.01% 3705
2015
Q3 		– Sell
-51,492
Closed -$779K – 4013
2015
Q2 		$779K Buy
+51,492
New +$744K ﹤0.01% 2878
2015
Q1 		– Sell
-677,778
Closed -$12.1M – 4157
2014
Q4 		$12.1M Buy
677,778
+10,626
+2% +$132K 0.02% 988
2014
Q3 		$6.7M Buy
667,152
+255,052
+62% +$3.09M 0.01% 1365
2014
Q2 		$6.43M Buy
412,100
+60,032
+17% +$851K 0.01% 1418
2014
Q1 		$6.53M Buy
352,068
+236,895
+206% +$4.75M 0.01% 1368
2013
Q4 		$2.2M Sell
115,173
-106,514
-48% -$2.16M ﹤0.01% 2435
2013
Q3 		$3.62M Sell
221,687
-16,065
-7% -$169K 0.01% 1883
2013
Q2 		$1.8M Buy
+237,752
New +$1.88M ﹤0.01% 2229

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

D.E. Shaw & Co's PETX Position: Q4 2017 in Review

D.E. Shaw & Co sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2017, closing a stake of 53,420 shares — an estimated $327K sold.

D.E. Shaw & Co first reported a position in PETX in Q2 2013 and held it in 15 quarters. The position peaked at $12.1M in Q4 2014. 105 funds tracked by Wall St. Rank hold PETX as of Q4 2017.

  • D.E. Shaw & Co reported no remaining Aratana Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 53,420 Aratana Therapeutics, Inc. shares in Q4 2017, an estimated $327K.
  • D.E. Shaw & Co first reported a position in Aratana Therapeutics, Inc. in Q2 2013 and held it in 15 quarters.
  • D.E. Shaw & Co's Aratana Therapeutics, Inc. position peaked at $12.1M in Q4 2014.
  • 105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2017.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.